Gentofte Hospital

22 trials 10 recruiting Commercial sponsor

Filter these 22 trials by condition, phase, country and more.

Open in Search →
22 Registered trials
10 Recruiting
10 Completed trials
3 Countries active
34 Unique IMPs
100% Results reported
Phase III: 2 Phase II: 9 Phase I/II: 1 Phase III/IV: 1 Phase IV: 9
100%

10 of 10 completed trials have published summary results (EU CTR Article 37 — 12-month obligation).

View full Transparency Scoreboard →

Top indications

Allergy test 1 Type 1 diabetes mellitus 1 Influenza 1 Herpes zoster 1 Arterial stiffness 1

Top IMPs

COLCHICINE 3 LEVOFLOXACIN 2 AMOXICILLIN TRIHYDRATE 1 ATORVASTATIN 1 AZITHROMYCIN 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), A/CAMBODIA/E0826360/2020 (H3N2)-LIKE STRAIN (A/CAMBODIA/E0826360/2020 IVR-224) 1 B/PHUKET/3073/2013-LIKE VIRUS (B/PHUKET/3073/2013, WILD TYPE), B/WASHINGTON/02/2019 - LIKE VIRUS (B/WASHINGTON/02/2019, WILD TYPE), A/VICTORIA/2570/2019 (H1N1)PDM09-LIKE STRAIN (A/VICTORIA/2570/2019, IVR-215), INFLUENZA A VIRUS, A/CAMBODIA/E0826360/2020 (H3N2) - LIKE STRAIN (A/TASMANIA/503/2020, IVR-221), INACTIVATED 1 BOTULINUM TOXIN TYPE A 1 BOTULINUM TOXIN TYPE A - HAEMAGGLUTININ COMPLEX 1 CLOSTRIDIUM BOTULINUM NEUROTOXIN TYPE A (150KD), FREE OF COMPLEXING PROTEINS 1 DAPIGLUTIDE 1 DELGOCITINIB 1

All trials

22 total

Showing 1–22 of 22 trials

← All sponsors A–Z